A Study of Subcutaneously Administered RoActemra/Actemra (Tocilizumab) in Patients With Rheumatoid Arthritis

Written by ClinicalTrials.gov

Category: Joint Diseases

Published: 30 August 2013

Condition: Rheumatoid Arthritis
Interventions: Drug: tocilizumab [RoActemra/Actemra]; Drug: methotrexate; Drug: DMARD
Sponsors: Hoffmann-La Roche; Hoffmann-La Roche
Not yet recruiting - verified September 2013

Details: Last Updated: 30 August 2013

Find, Use, Share, Expand Orthopaedic Information

Improving orthopaedic care, education and research using Internet technologies